Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Clinical correlates of herpes simplex virus type 1 loads in the lower respiratory tract of critically ill patients.

Assink-de Jong E, Groeneveld AB, Pettersson AM, Koek A, Vandenbroucke-Grauls CM, Beishuizen A, Simoons-Smit AM.

J Clin Virol. 2013 Sep;58(1):79-83. doi: 10.1016/j.jcv.2013.05.007. Epub 2013 May 31.

PMID:
23731844
2.

Evolution and viral characteristics of a long-term circulating resistant HIV-1 strain in a cluster of treatment-naive patients.

Hofstra LM, Nijhuis M, Pingen M, Mudrikova T, Riezebos-Brilman A, Simoons-Smit AM, Van Ham PM, Bierman WF, Wensing AM.

J Antimicrob Chemother. 2013 Jun;68(6):1246-50. doi: 10.1093/jac/dkt038. Epub 2013 Mar 6.

PMID:
23467175
3.

Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots.

Ang CW, Notermans DW, Hommes M, Simoons-Smit AM, Herremans T.

Eur J Clin Microbiol Infect Dis. 2011 Aug;30(8):1027-32. doi: 10.1007/s10096-011-1157-6. Epub 2011 Jan 27.

4.

Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.

Timmers GJ, Simoons-Smit AM, Leidekker ME, Janssen JJ, Vandenbroucke-Grauls CM, Huijgens PC.

Clin Microbiol Infect. 2007 May;13(5):497-503. Epub 2007 Jan 30.

5.

Rapid identification of pathogens in blood cultures with a modified fluorescence in situ hybridization assay.

Peters RP, van Agtmael MA, Simoons-Smit AM, Danner SA, Vandenbroucke-Grauls CM, Savelkoul PH.

J Clin Microbiol. 2006 Nov;44(11):4186-8.

6.

Herpes simplex virus type 1 and respiratory disease in critically-ill patients: Real pathogen or innocent bystander?

Simoons-Smit AM, Kraan EM, Beishuizen A, Strack van Schijndel RJ, Vandenbroucke-Grauls CM.

Clin Microbiol Infect. 2006 Nov;12(11):1050-9. Review.

7.

Faster identification of pathogens in positive blood cultures by fluorescence in situ hybridization in routine practice.

Peters RP, Savelkoul PH, Simoons-Smit AM, Danner SA, Vandenbroucke-Grauls CM, van Agtmael MA.

J Clin Microbiol. 2006 Jan;44(1):119-23.

8.

Cefpirome as empirical treatment for febrile neutropenia in patients with hematologic malignancies.

Timmers GJ, van Vuurden DG, Swart EL, Simoons-Smit AM, Huijgens PC.

Haematologica. 2005 Jul;90(7):1005-6.

9.

Herpes simplex virus type 1 and normal protein permeability in the lungs of critically ill patients: a case for low pathogenicity?

Verheij J, Groeneveld AB, Beishuizen A, van Lingen A, Simoons-Smit AM, van Schijndel RJ.

Crit Care. 2004 Jun;8(3):R139. Epub 2004 Mar 31.

10.

Respiratory herpes simplex virus type 1 infection/colonisation in the critically ill: marker or mediator?

van den Brink JW, Simoons-Smit AM, Beishuizen A, Girbes AR, Strack van Schijndel RJ, Groeneveld AB.

J Clin Virol. 2004 May;30(1):68-72.

PMID:
15072757
11.

Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies.

Timmers GJ, Dijstelbloem Y, Simoons-Smit AM, van Winkelhoff AJ, Touw DJ, Vandenbroucke-Grauls CM, Huijgens PC.

Bone Marrow Transplant. 2004 Apr;33(8):847-53.

PMID:
14755314
12.

Pyelonephritis caused by Actinobaculum schaalii in a child with pyeloureteral junction obstruction.

Pajkrt D, Simoons-Smit AM, Savelkoul PH, van den Hoek J, Hack WW, van Furth AM.

Eur J Clin Microbiol Infect Dis. 2003 Jul;22(7):438-40. Epub 2003 Jun 17.

PMID:
12811591
13.

Chronic cystitis caused by Corynebacterium urealyticum detected by polymerase chain reaction.

Simoons-Smit AM, Savelkoul PH, Newling DW, Vandenbroucke-Grauls CM.

Eur J Clin Microbiol Infect Dis. 2000 Dec;19(12):949-52.

PMID:
11205634
14.

[Manifestations of histoplasmosis].

Claessen FA, Vos MJ, Simoons-Smit AM, Debets-Ossenkopp YJ, Perenboom RM.

Ned Tijdschr Geneeskd. 2000 Jun 17;144(25):1201-5. Review. Dutch.

PMID:
10897298
15.

Role of bacterial virulence factors and host factors in the outcome of Escherichia coli bacteraemia.

Hekker TA, Groeneveld AB, Simoons-Smit AM, de Man P, Connell H, MacLaren DM.

Eur J Clin Microbiol Infect Dis. 2000 Apr;19(4):312-6.

PMID:
10834824
16.

Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial.

Timmers GJ, Zweegman S, Simoons-Smit AM, van Loenen AC, Touw D, Huijgens PC.

Bone Marrow Transplant. 2000 Apr;25(8):879-84.

17.

Transmission of Staphylococcus aureus between humans and domestic animals in a household.

Simoons-Smit AM, Savelkoul PH, Stoof J, Starink TM, Vandenbroucke-Grauls CM.

Eur J Clin Microbiol Infect Dis. 2000 Feb;19(2):150-2. No abstract available.

PMID:
10746507
18.

Itraconazole verus fluconazole in neutropenic patients.

Huijgens PC, Timmers GJ, Simoons-Smit AM, Van Loenen AC.

Br J Haematol. 2000 Jan;108(1):196. No abstract available.

PMID:
10712003
19.

Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.

Huijgens PC, Simoons-Smit AM, van Loenen AC, Prooy E, van Tinteren H, Ossenkoppele GJ, Jonkhoff AR.

J Clin Pathol. 1999 May;52(5):376-80.

20.

[Antibiotics and dentistry].

Smeele LE, Simoons-Smit AM.

Ned Tijdschr Tandheelkd. 1994 Dec;101(12):489-91. Dutch.

PMID:
11830837
22.

The prophylactic use of fluconazole 50 vs. 100 mg daily in haematological malignancies.

Huijgens PC, van Loenen AC, Simoons-Smit AM, Prooy E, Ossenkoppele GJ.

Eur J Cancer. 1993;29A(6):926-7. No abstract available.

PMID:
8484989
23.

Imipenem-cilastatin for empirical therapy in neutropenic patients with fever: an open study in patients with hematologic malignancies.

Huijgens PC, Ossenkoppele GJ, Weijers TF, van Loenen AC, Simoons-Smit AM, Wijermans PW, van Pampus EC, Langenhuijsen MM.

Eur J Haematol. 1991 Jan;46(1):42-6.

PMID:
1988306
24.

Correlations between consumption of antibiotics and methicillin resistance in coagulase negative staphylococci.

Mouton RP, Hermans J, Simoons-Smit AM, Hoogkamp-Korstanje JA, Degener JE, van Klingeren B.

J Antimicrob Chemother. 1990 Oct;26(4):573-83.

PMID:
2254225
25.

Carriage of Staphylococcus aureus and inflamed infusion sites with insulin-pump therapy.

van Faassen I, Razenberg PP, Simoons-Smit AM, van der Veen EA.

Diabetes Care. 1989 Feb;12(2):153-5.

PMID:
2702898
26.
27.

[Encephalitis in Mycoplasma pneumoniae infections].

Lanting P, Strack van Schijndel RJ, Simoons-Smit AM, Visscher F.

Ned Tijdschr Geneeskd. 1987 Nov 21;131(47):2146-9. Dutch. No abstract available.

PMID:
3120018
28.

The role of K antigens as virulence factors in Klebsiella.

Simoons-Smit AM, Verweij-van Vught AM, MacLaren DM.

J Med Microbiol. 1986 Mar;21(2):133-7.

PMID:
3512838
29.

Biochemical and serological investigations on clinical isolates of klebsiella.

Simoons-Smit AM, Verweij-Van Vught AM, Kanis IY, MacLaren DM.

J Hyg (Lond). 1985 Oct;95(2):265-76.

30.

Another source of aerosol causing nosocomial Legionnaires' disease.

Kaan JA, Simoons-Smit AM, MacLaren DM.

J Infect. 1985 Sep;11(2):145-8.

PMID:
4056449
31.

Chemiluminescence of human leukocytes stimulated by clinical isolates of Klebsiella.

Simoons-Smit AM, Verweij-van Vught AM, Kanis IY, MacLaren DM.

J Med Microbiol. 1985 Jun;19(3):333-8.

PMID:
4009688
32.

Virulence of Klebsiella strains in experimentally induced skin lesions in the mouse.

Simoons-Smit AM, Verwey-van Vught AM, Kanis IY, MacLaren DM.

J Med Microbiol. 1984 Feb;17(1):67-77.

PMID:
6363708
33.

Comparison of different methods for bacteriocin typing of Klebsiella strains.

Simoons-Smit AM, Verweij-van Vught AM, Kanis IY, Maclaren DM.

J Hyg (Lond). 1983 Jun;90(3):461-73.

Supplemental Content

Loading ...
Support Center